The Food and Drug Administration Friday approved a stroke-prevention medicine that will compete in that category against the blood-thinner warfarin, which is sometimes sold under the name Coumadin. The FDA issued a news release saying that it had given the go-ahead to the anti-clotting drug Eliquis, or apixaban, an oral..
Read more
Date: 9/24/2008 6:52 PM By ALICIA CHANGAP Science Writer LOS ANGELES (AP) _ Stroke sufferers can still benefit from clot-busting medicine even if they receive it an hour or so beyond the current three-hour window after symptoms start, an important new study suggests. The finding could potentially extend treatment to..
Read more
Brain Injury Law Group
Attorney Gordon S. Johnson, Jr.
212 Whitetail Run Ln.
Sheboygan, Wisconsin
800-992-9447
Email Us
ADVERTISING MATERIAL
Brought to you by The Brain Injury Law Group, SC. The materials on this web page are provided purely for informational purposes. They are not intended to be legal advice. This information is intended, but not promised or guaranteed, to be correct, complete, and current. While this page is not intended to be a source of advertising, solicitation or legal advice, it could be deemed to be such.
TBI Voices TBI Law
Print Friendly Version
Save Page as PDF